The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
Open accessAbstract
Purpose: To provide evidence-based guidance on the optimum prevention and treatment approaches in the management of chemotherapy-induced peripheral neuropathies (CIPN) in adult cancer survivors. Methods: A systematic literature search identified relevant, randomized controlled trials (RCTs) for the treatment of CIPN. Primary outcomes included incidence and severity of neuropathy as measured by neurophysiologic changes, patient-reported outcomes, and quality of life. Results: A total of 48 RCTs met eligibility criteria and comprise the evidentiary basis for the recommendations. Trials tended to be small and heterogeneous, many with insufficient sample sizes to detect clinically important differences in outcomes. Primary outcomes varied across the trials, and in most cases, studies were not directly comparable because of different outcomes, measurements, and instruments used at different time points. The strength of the recommendations is based on the quality, amount, and consistency of the evidence and the balance between benefits and harms. Recommendations: On the basis of the paucity of high-quality, consistent evidence, there are no agents recommended for the prevention of CIPN. With regard to the treatment of existing CIPN, the best available data support a moderate recommendation for treatment with duloxetine. Although the CIPN trials are inconclusive regarding tricyclic antidepressants (such as nortriptyline), gabapentin, and a compounded topical gel containing baclofen, amitriptyline HCL, and ketamine, these agents may be offered on the basis of data supporting their utility in other neuropathic pain conditions given the limited other CIPN treatment options. Further research on these agents is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Smith, E. M. L., Pang, H., Cirrincione, C., Fleishman, S., Paskett, E. D., Ahles, T., Bressler, L. R., Fadul, C. E., Knox, C., Le-Lindqwister, N., et al. (2013) · JAMA · doi:10.1001/jama.2013.2813 · Cited by 1,014
Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies
Wolf, S., Barton, D., Kottschade, L., Grothey, A., & Loprinzi, C. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.04.018 · Cited by 632
Self-citationPostma, T. J., Aaronson, N. K., Heimans, J. J., Muller, M. J., Hildebrand, J. G., Delattre, J. Y., Hoang-Xuan, K., Lantéri-Minet, M., Grant, R., Huddart, R., et al. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.02.012 · Cited by 583
Chemotherapy-induced peripheral neurotoxicity (CIPN): An update
Argyriou, A. A., Bruna, J., Marmiroli, P., & Cavaletti, G. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.04.012 · Cited by 568
Self-citationKemp, G., Rose, P., Lurain, J., Berman, M., Manetta, A., Roullet, B., Homesley, H., Belpomme, D., & Glick, J. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.7.2101 · Cited by 463
Total neuropathy score: Validation and reliability study
Cornblath, D. R., Chaudhry, V., Carter, K., Lee, D., Seysedadr, M., Miernicki, M., & Joh, T. (1999) · Neurology · doi:10.1212/wnl.53.8.1660 · Cited by 449
Cascinu, S., Catalano, V., Cordella, L., Labianca, R., Giordani, P., Baldelli, A. M., Beretta, G. D., Ubiali, E., & Catalano, G. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.061 · Cited by 421
Calhoun, E. A., Welshman, E. E., Chang, C.-H., Lurain, J. R., Fishman, D. A., Hunt, T. L., & Cella, D. (2003) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2003.13603.x · Cited by 392
Prevention of Oxaliplatin-Related Neurotoxicity by Calcium and Magnesium Infusions
Gamelin, L., Boisdron‐Celle, M., Delva, R., Guerin‐Meyer, V., Ifrah, N., Morel, A., & Gamelin, E. C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0666 · Cited by 385
Dworkin, R. H., Turk, D. C., Peirce-Sandner, S., Baron, R., Bellamy, N., Burke, L. B., Chappell, A., Chartier, K., Cleeland, C. S., Costello, A., et al. (2010) · Pain · doi:10.1016/j.pain.2010.02.018 · Cited by 381
Self-citationRao, R. D., Michalak, J. C., Sloan, J. A., Loprinzi, C. L., Soori, G. S., Nikcevich, D. A., Warner, D. O., Novotny, P., Kutteh, L. A., Wong, G. Y., et al. (2007) · Cancer · doi:10.1002/cncr.23008 · Cited by 360
Self-citationGamelin, E., Gamelin, L., Bossi, L., & Quasthoff, S. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.35525 · Cited by 321
Peripheral Neuropathy Induced by Paclitaxel: Recent Insights and Future Perspectives
Scripture, C., Figg, W., & Sparreboom, A. (2006) · Current Neuropharmacology · doi:10.2174/157015906776359568 · Cited by 320
American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.04187.x · Cited by 308
Neuroprotective Effect of Vitamin E Supplementation in Patients Treated With Cisplatin Chemotherapy
Pace, A., Savarese, A., Picardo, M., Maresca, V., Pacetti, U., Del Monte, G., Biroccio, A., Leonetti, C., Jandolo, B., Cognetti, F., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.139 · Cited by 307
Interventions for preventing neuropathy caused by cisplatin and related compounds
Albers, J. W., Chaudhry, V., Cavaletti, G., & Donehower, R. C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005228.pub4 · Cited by 298
Self-citationCavaletti, G., Cornblath, D. R., Merkies, I. S. J., Postma, T. J., Rossi, E., Frigeni, B., Alberti, P., Bruna, J., Velasco, R., Argyriou, A. A., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds329 · Cited by 293
Self-citationPrevention of Cisplatin Neurotoxicity with an ACTH(4–9) Analogue in Patients with Ovarian Cancer
van der Hoop, R. G., Vecht, C. J., van der Burg, M. E. L., Elderson, A., Boogerd, W., Heimans, J. J., Vries, E. P., van Houwelingen, J. C., Jennekens, F. G. I., Gispen, W. H., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001113220204 · Cited by 287
Natural History of Paclitaxel-Associated Acute Pain Syndrome: Prospective Cohort Study NCCTG N08C1
Loprinzi, C. L., Reeves, B. N., Dakhil, S. R., Sloan, J. A., Wolf, S. L., Burger, K. N., Kamal, A., Le-Lindqwister, N. A., Soori, G. S., Jaslowski, A. J., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.0308 · Cited by 281
Self-citationCavaletti, G., Frigeni, B., Lanzani, F., Mattavelli, L., Susani, E., Alberti, P., Cortinovis, D., & Bidoli, P. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2009.12.008 · Cited by 274
Self-citationChemotherapy-Induced Peripheral Neuropathy: Prevention and Treatment
Pachman, D. R., Barton, D. L., Watson, J. C., & Loprinzi, C. L. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.115 · Cited by 268
Self-citationHershman, D. L., Weimer, L. H., Wang, A., Kranwinkel, G., Brafman, L., Fuentes, D., Awad, D., & Crew, K. D. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1278-0 · Cited by 264
Self-citationNCCN Task Force Report: Management of Neuropathy in Cancer
Stubblefield, M. D., Burstein, H. J., Burton, A. W., Custodio, C. M., Deng, G. E., Ho, M., Junck, L., Morris, G. S., Paice, J. A., Tummala, S., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0078 · Cited by 257
Self-citationBarton, D. L., Wos, E. J., Qin, R., Mattar, B. I., Green, N. B., Lanier, K. S., Bearden, J. D., Kugler, J. W., Hoff, K. L., Reddy, P. S., et al. (2011) · Supportive Care in Cancer · doi:10.1007/s00520-010-0911-0 · Cited by 255
Self-citationHammack, J. E., Michalak, J. C., Loprinzi, C. L., Sloan, J. A., Novotny, P. J., Soori, G. S., Tirona, M. T., Rowland, K. M., Stella, P. J., & Johnson, J. A. (2002) · Pain · doi:10.1016/s0304-3959(02)00047-7 · Cited by 231
Self-citationCampbell, P. T., Patel, A. V., Newton, C. C., Jacobs, E. J., & Gapstur, S. M. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.9735 · Cited by 229
Wiener klinische Wochenschrift
(2013) · Wiener klinische Wochenschrift · doi:10.1007/508.1613-7671 · Cited by 229
Durand, J. P., Deplanque, G., Montheil, V., Gornet, J. M., Scotte, F., Mir, O., Cessot, A., Coriat, R., Raymond, E., Mitry, E., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr045 · Cited by 217
Hershman, D. L., Unger, J. M., Crew, K. D., Minasian, L. M., Awad, D., Moinpour, C. M., Hansen, L., Lew, D. L., Greenlee, H., Fehrenbacher, L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.8738 · Cited by 214
Self-citationAmitriptyline in the Treatment of Chemotherapy-Induced Neuropathic Symptoms
Kautio, A.-L., Haanpää, M., Saarto, T., & Kalso, E. (2008) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2007.02.043 · Cited by 213
Wang, W.-S., Lin, J.-K., Lin, T.-C., Chen, W.-S., Jiang, J.-K., Wang, H.-S., Chiou, T.-J., Liu, J.-H., Yen, C.-C., & Chen, P.-M. (2007) · The Oncologist · doi:10.1634/theoncologist.12-3-312 · Cited by 210
Binkley, J. M., Harris, S. R., Levangie, P. K., Pearl, M., Guglielmino, J., Kraus, V., & Rowden, D. (2012) · Cancer · doi:10.1002/cncr.27469 · Cited by 207
Baldwin, R. M., Owzar, K., Zembutsu, H., Chhibber, A., Kubo, M., Jiang, C., Watson, D., Eclov, R. J., Mefford, J., McLeod, H. L., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1590 · Cited by 204
Grothey, A., Nikcevich, D. A., Sloan, J. A., Kugler, J. W., Silberstein, P. T., Dentchev, T., Wender, D. B., Novotny, P. J., Chitaley, U., Alberts, S. R., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.5911 · Cited by 198
Self-citationRao, R. D., Flynn, P. J., Sloan, J. A., Wong, G. Y., Novotny, P., Johnson, D. B., Gross, H. M., Renno, S. I., Nashawaty, M., & Loprinzi, C. L. (2008) · Cancer · doi:10.1002/cncr.23482 · Cited by 193
Self-citationVitamin E neuroprotection for cisplatin neuropathy: A randomized, placebo-controlled trial
Pace, A., Giannarelli, D., Galiè, E., Savarese, A., Carpano, S., Della Giulia, M., Pozzi, A., Silvani, A., Gaviani, P., Scaioli, V., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d5279e · Cited by 191
Alberti, P., Rossi, E., Cornblath, D. R., Merkies, I. S. J., Postma, T. J., Frigeni, B., Bruna, J., Velasco, R., Argyriou, A. A., Kalofonos, H. P., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdt409 · Cited by 179
Self-citationSmyth, J. F., Bowman, A., Perren, T., Wilkinson, P., Prescott, R. J., Quinn, K. J., & Tedeschi, M. (1997) · Annals of Oncology · doi:10.1023/a:1008211226339 · Cited by 178
Kottschade, L. A., Sloan, J. A., Mazurczak, M. A., Johnson, D. B., Murphy, B. P., Rowland, K. M., Smith, D. A., Berg, A. R., Stella, P. J., & Loprinzi, C. L. (2011) · Supportive Care in Cancer · doi:10.1007/s00520-010-1018-3 · Cited by 173
Self-citationGhoreishi, Z., Esfahani, A., Djazayeri, A., Djalali, M., Golestan, B., Ayromlou, H., Hashemzade, S., Asghari Jafarabadi, M., Montazeri, V., Keshavarz, S. A., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-355 · Cited by 171
The European Organisation for Research and Treatment of Cancer
Camidge, R. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(01)00626-x · Cited by 165
Reeves, B. N., Dakhil, S. R., Sloan, J. A., Wolf, S. L., Burger, K. N., Kamal, A., Le‐Lindqwister, N. A., Soori, G. S., Jaslowski, A. J., Kelaghan, J., et al. (2012) · Cancer · doi:10.1002/cncr.27489 · Cited by 161
Self-citationTanabe, Y., Hashimoto, K., Shimizu, C., Hirakawa, A., Harano, K., Yunokawa, M., Yonemori, K., Katsumata, N., Tamura, K., Ando, M., et al. (2013) · International Journal of Clinical Oncology · doi:10.1007/s10147-011-0352-x · Cited by 160
Cascinu, S., Cordella, L., Ferro, E. D., Fronzoni, M., & Catalano, G. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.26 · Cited by 158
Speck, R. M., Sammel, M. D., Farrar, J. T., Hennessy, S., Mao, J. J. J., Stineman, M. G., & DeMichele, A. M. (2013) · Journal of Oncology Practice · doi:10.1200/jop.2012.000863 · Cited by 144
Argyriou, A. A., Chroni, E., Koutras, A. K., Iconomou, G., Papapetropoulos, S., Polychronopoulos, P., & Kalofonos, H. P. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-006-0072-3 · Cited by 138
Wolf, S. L., Barton, D. L., Qin, R., Wos, E. J., Sloan, J. A., Liu, H., Aaronson, N. K., Satele, D., Mattar, B. I., Green, N. B., et al. (2011) · Supportive Care in Cancer · doi:10.1007/s00520-011-1141-9 · Cited by 132
Self-citationLin, P., Lee, M.-Y., Wang, W.-S., Yen, C., Chao, T., Hsiao, L., Yang, M., Chen, P., Lin, K., & Chiou, T.-J. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-006-0018-9 · Cited by 125
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics
Cavaletti, G., Alberti, P., & Marmiroli, P. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70131-0 · Cited by 123
Self-citationCYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel
Hertz, D. L., Roy, S., Motsinger‐Reif, A. A., Drobish, A. A., Clark, L. S., McLeod, H. L., Carey, L., & Dees, E. C. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt018 · Cited by 116
Impact of oxaliplatin-induced neuropathy: a patient perspective
Bennett, B. K., Park, S. B., Lin, C. S.-Y., Friedlander, M. L., Kiernan, M. C., & Goldstein, D. (2012) · Supportive Care in Cancer · doi:10.1007/s00520-012-1428-5 · Cited by 115
Grothey, A., Hart, L. L., Rowland, K. M., Ansari, R., Alberts, S. R., Chowhan, N. M., Shpilsky, A., & Hochster, H. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.4010 · Cited by 114
Stubblefield, M. D., McNeely, M. L., Alfano, C. M., & Mayer, D. K. (2012) · Cancer · doi:10.1002/cncr.27463 · Cited by 112
Griffith, K. A., Merkies, I. S. J., Hill, E., & Cornblath, D. R. (2010) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2010.00292.x · Cited by 110
The effects of thalidomide and minocycline on taxol-induced hyperalgesia in rats
Cata, J. P., Weng, H., & Dougherty, P. M. (2008) · Brain Research · doi:10.1016/j.brainres.2008.07.001 · Cited by 109
Marineo, G., Iorno, V., Gandini, C., Moschini, V., & Smith, T. J. (2011) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2011.03.015 · Cited by 109
Self-citationDavis, I. D., Kiers, L., MacGregor, L., Quinn, M. A., Arezzo, J. C., Green, M., Rosenthal, M. A., Chia, M. M., Michael, M., Bartley, P., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1655 · Cited by 109
The Paclitaxel Acute Pain Syndrome: Sensitization of Nociceptors as the Putative Mechanism
Loprinzi, C. L., Maddocks‐Christianson, K., Wolf, S. L., Rao, R. D., Dyck, P. J. B., Mantyh, P. W., & Dyck, P. J. B. (2007) · The Cancer Journal · doi:10.1097/ppo.0b013e31815a999b · Cited by 108
Self-citationAmitriptyline in the prevention of chemotherapy-induced neuropathic symptoms.
Kautio, A.-L., Haanpää, M. L., Leminen, A., Kalso, E. A., Kautiainen, H., & Saarto, T. H. (2009) · PubMed · Cited by 106
Zaks‐Zilberman, M., Zaks, T. Z., & Vogel, S. N. (2001) · Cytokine · doi:10.1006/cyto.2001.0935 · Cited by 106
Smith, T. J., Coyne, P. J., Parker, G. L., Dodson, P. W., & Ramakrishnan, V. (2010) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2010.03.022 · Cited by 106
Self-citationPlanting, A. S. T., Catimel, G., Mulder, P. H. M. D., de Graeff, A., Höppener, F., Verweij, I., Oster, W., & Vermorken, J. B. (1999) · Annals of Oncology · doi:10.1023/a:1008353505916 · Cited by 99
The use of complementary and alternative medicines by patients with peripheral neuropathy
Brunelli, B., & Gorson, K. C. (2003) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2003.10.013 · Cited by 95
Leal, A. D., Qin, R., Atherton, P. J., Haluska, P., Behrens, R. J., Tiber, C. H., Watanaboonyakhet, P., Weiss, M., Adams, P. T., Dockter, T., et al. (2014) · Cancer · doi:10.1002/cncr.28654 · Cited by 92
Self-citationThe Total Neuropathy Score: A Tool for Measuring Chemotherapy-Induced Peripheral Neuropathy
Smith, E., Beck, S. L., & Cohen, J. (2008) · Oncology nursing forum · doi:10.1188/08.onf.96-102 · Cited by 92
Arrieta, O. G., Hernández‐Pedro, N., Aragón, M. C. F.-G., Saavedra-Pérez, D., Campos-Parra, A. D., Ríos-Trejo, M. Á., Cerón-Lizárraga, T., Martínez-Barrera, L. M., Pineda, B., Ordóñez, G., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31822e045c · Cited by 80
Milla, P., Airoldi, M., Weber, G., Drescher, A., Jaehde, U., & Cattel, L. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32832a2dc1 · Cited by 76
Gandara, D. R., Nahhas, W. A., ADELSON, M. D., Lichtman, S. M., Podczaski, E. S., Yanovich, S., Homesley, H. D., Braly, P. D., Ritch, P. S., & Weisberg, S. R. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.2.490 · Cited by 74
White, C. M., Martin, B. K., Lee, L., Haskill, J. S., & Ting, J. P. ‐. (1998) · Cancer Immunology Immunotherapy · doi:10.1007/s002620050468 · Cited by 72
Hilpert, F., Stähle, A., Tomé, O., et al. (2005) · Supportive Care in Cancer · doi:10.1007/s00520-005-0782-y · Cited by 70
Ishibashi, K., Okada, N., Miyazaki, T., Sano, M., & Ishida, H. (2010) · International Journal of Clinical Oncology · doi:10.1007/s10147-009-0015-3 · Cited by 68
Sucheston, L. E., Zhao, H., Yao, S., Zirpoli, G., Liu, S., Barlow, W. E., Moore, H. C. F., Budd, G. T., Hershman, D. L., Davis, W., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1671-3 · Cited by 68
Self-citationThe course of neuropathy after cessation of cisplatin treatment, combined with Org 2766 or placebo
Hovestadt, A., van der Burg, M. E. L., Verbiest, H. B. C., van Putten, W. L. J., & Vecht, C. J. (1992) · Journal of Neurology · doi:10.1007/bf00833914 · Cited by 56
Kooten, B. V., van Diemen, H. A. M., Groenhout, K. M., Huijgens, P. C., Ossenkoppele, G. J., Nauta, J. J. P., & Heimans, J. J. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530340043016 · Cited by 46
Schneider, B. P., Li, L., Miller, K. D., Flockhart, D. A., Radovich, M., Hancock, B. A., Kassem, N., Foroud, T., Koller, D. L., Badve, S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.29.15_suppl.1000 · Cited by 44
Self-citationvan Gerven, J., Hovestadt, A., Moll, J. W. B., et al. (1994) · Journal of Neurology · doi:10.1007/bf00900961 · Cited by 34
Inoue, N., Ishida, H., Sano, M., Kishino, T., Okada, N., Kumamoto, K., & Ishibashi, K. (2011) · International Journal of Clinical Oncology · doi:10.1007/s10147-011-0298-z · Cited by 29
Utilizing natural activity to dissect the pathophysiology of acute oxaliplatin-induced neuropathy
Park, S. B., Lin, C. S.-Y., Krishnan, A. V., Goldstein, D., Friedlander, M. L., & Kiernan, M. C. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.10.002 · Cited by 26
Campbell, T. C., Nimunkar, A. J., Retseck, J., Eickhoff, J. C., Bačkonja, M., Cleary, J. F., Kwekkeboom, K. L., & Yen, T. Y. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.9635 · Cited by 16
Cited by
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., Gilron, I., Haanpää, M., Hansson, P., Jensen, T. S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70251-0 · Cited by 3,980
Self-citationHarbeck, N., Penault-Llorca, F., Cortes, J., Gnant, M., Houssami, N., Poortmans, P., Ruddy, K., Tsang, J., & Cardoso, F. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0111-2 · Cited by 3,024
Seretny, M., Currie, G. L., Sena, E. S., Ramnarine, S., Grant, R., MacLeod, M. R., Colvin, L. A., & Fallon, M. (2014) · Pain · doi:10.1016/j.pain.2014.09.020 · Cited by 1,555
“The development of CIPN may require chemotherapy dose reduction or cessation, which can increase cancer-related morbidity and mortality [17,31].”
Runowicz, C. D., Leach, C. R., Henry, N. L., Henry, K. S., Mackey, H. T., Cowens-Alvarado, R. L., Cannady, R. S., Pratt-Chapman, M. L., Edge, S. B., Jacobs, L. A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.3809 · Cited by 1,071
Masters, G. A., Temin, S., Azzoli, C. G., Giaccone, G., Baker, S., Brahmer, J. R., Ellis, P. M., Gajra, A., Rackear, N., Schiller, J. H., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.1342 · Cited by 850
Self-citation
Metadata
- Authors
- Hershman, D. L., Lacchetti, C., Dworkin, R. H., Lavoie Smith, E. M., Bleeker, J., Cavaletti, G., Chauhan, C., Gavin, P., Lavino, A., Lustberg, M. B., Paice, J., Schneider, B., Smith, M. L., Smith, T., Terstriep, S., Wagner-Johnston, N., Bak, K., & Loprinzi, C. L.
- Venue
- Journal of Clinical Oncology
- Published
- 2014-06-20
- Volume
- 32
- Issue
- 18
- Pages
- 1941-1967
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2149603226
- Cited by
- 1,209
- References
- 80
- FWCI
- 50.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.